Wellness App for Sleep Disturbance in Hematological Cancer Patients
Eligible age
18+ yrs
Accepts
All genders
Locations
3 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
In a randomized controlled trial (RCT), the investigators will recruit participants to an 8-week "app-based wellness" intervention, followed by a 12-week follow-up period. The investigators will recruit a total of 276 self-declared Chronic Hematological Cancer (CHC) patients who (representative of age, race/ethnicity, and gender) will be on stable CHC pharmacologic therapy (if any), self-identify as sleep disturbed (\>5 on Pittsburgh Sleep Quality Index), do not have a sleep disorder diagnosis, do not take sleep medication/supplements \>3 times per week, and are not currently practicing regular meditation. Aim 1: Test the efficacy of two app-based wellness programs (10 minutes per day) on the primary outcome of self reported sleep disturbance (Insomnia Severity Index (primary) and PROMIS Sleep Disturbance (secondary)) and secondary sleep outcomes including sleep impairment (PROMIS Sleep Impairment Scale) and sleep efficiency measured via sleep diaries and actigraphy. Aim 2: Test the efficacy of two app-based wellness programs (10 minutes per day) on inflammatory markers (i.e., TNF-a, IL-6, IL-8, CRP), fatigue, and emotional distress (i.e., anxiety, depressive symptoms measured with PROMIS®). Aim 3: Explore the sustained effects (i.e., 20 weeks from baseline) of two app-based wellness programs (10 minutes per day) in CHC patients.
Sponsor: The University of Texas Health Science Center at San Antonio
You may qualify if…
- ✓ 1. Self-declared diagnosis of hematological cancer on stable maintenance management\* by treating physician (i.e., on stable medical therapy) or observation (i.e., no changes in disease targeted medications for the past two weeks)
- ✓ 2. Not currently participating in a therapeutic pharmacologic clinical trial
- ✓ 3. Not planning to receive an allogenic stem cell transplantation during the study time frame (i.e., 20 weeks)
- ✓ 4. Score of \>5 on PSQI (Pittsburgh Sleep Quality Index)
- ✓ 5. Own a mobile smartphone (iPhone with iOS 14 or later or an Android 6 or later) with an active data or WiFi connection
- ✓ 6. Willing to download two mobile apps
- ✓ 7. Able to read/understand English
- ✓ 8. ≥18 years of age
You may not qualify if…
- ✕ 1. Self-report meditation practice or meditative movement practice (i.e., yoga, tai chi, qi gong) of ≥60 min/week in past 2 months
- ✕ 2. Reside outside of the United States of America
- ✕ 3. Any planned change to a new pharmacologic therapy (i.e., new drug) for the treatment of their cancer diagnosis (excluding dose changes)
- ✕ 4. Diagnosed with a sleep disorder except insomnia (≥2 positive categories on Berlin Questionnaire)
- ✕ 5. Taking prescribed sleep medications and/or over-the-counter drugs/supplements (including drugs like NyQuil, Benadryl, and other antihistamine-based drugs) on ≥3 nights per week
- ✕ 6. Any other diagnosed and uncontrolled medical or psychiatric condition
- ✕ 7. Has a pacemaker
- ✕ 8. Shift work schedule
Where it's recruiting
Source: ClinicalTrials.gov · NCT05294991 · last updated 2026-02-19